{"abstract":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the U.S. Patents and Patent Applications listed in the Supplementary Information section of this notice to Cyprium Therapeutics, Inc. (\"Cyprium\") located in New York, NY, USA.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/09/26/2016-23134.html","cfr_references":[],"citation":"81 FR 66047","comment_url":null,"comments_close_on":"2016-10-11","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before October 11, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2016-23134","effective_on":null,"end_page":66048,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/09/26/2016-23134.xml","html_url":"https://www.federalregister.gov/documents/2016/09/26/2016-23134/prospective-grant-of-exclusive-patent-license-development-of-adeno-associated-virus-based-vectors","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-23134?publication_date=2016-09-26","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-09-26/2016-23134/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":150,"last_updated":"2026-06-25 00:15:02 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-09-26/pdf/2016-23134.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-23134.pdf?1474634791","publication_date":"2016-09-26","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/09/26/2016-23134.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T00:30:00Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":66047,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Development of Adeno-Associated Virus-Based Vectors for the Treatment of Menkes Disease and Related Copper Transport Disorders","toc_doc":"Development of Adeno-Associated Virus-Based Vectors for the Treatment of Menkes Disease and Related Copper Transport Disorders","toc_subject":"Prospective Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":81}